{"prompt": "Procedure Code: Robotic Bronchoscopy with EBUS. Patient: 78 F. Targets: RUL RB3, RLL RB9, LUL LB4. Specimen collected: TBNA, Cryo, Brush, BAL. Fiducials placed.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Chen\n\nINDICATION FOR OPERATION: The patient is a 78-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Lateral Basal Segment RB9) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Lateral Basal Segment of the RLL (RB9).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n78-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Write an op note for a 79 year old female patient. Procedure was Robotic Navigation Bronchoscopy using the Ion system. We targeted three lesions: RUL Apical Segment, RLL Superior Segment, and LUL Superior Lingular Segment. We did TBNA, cryo, brush, and BAL for all. Also did EBUS staging, but no nodes were sampled.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Rodriguez\n\nINDICATION FOR OPERATION: The patient is a 79-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 12; TV: 400; PEEP: 8; FiO2: 80%; Flow Rate: 12;\nPmean: 14.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n79-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Operative Report. 58yo F, Dr. Patel. Robotic bronch Ion 3 targets: RUL RB2, RLL RB7, LUL LB4. All fiducials placed. EBUS neg.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Patel\n\nINDICATION FOR OPERATION: The patient is a 58-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 12; TV: 400; PEEP: 8; FiO2: 80%; Flow Rate: 12;\nPmean: 14.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Medial Basal Segment RB7) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Medial Basal Segment of the RLL (RB7).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n58-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Procedure Code: Robotic Bronchoscopy with EBUS. Patient: 63 F. Targets: RUL RB2, RLL RB10, LUL LB3. Specimen collected: TBNA, Cryo, Brush, BAL. Fiducials placed.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Patel\n\nINDICATION FOR OPERATION: The patient is a 63-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 12; TV: 400; PEEP: 8; FiO2: 80%; Flow Rate: 12;\nPmean: 14.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Posterior Basal Segment RB10) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with discontinuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Anterior Segment LB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Anterior Segment of the LUL (LB3).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n63-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "77 M lung nodules. Robotic bronch + EBUS. Targets: RUL (RB3), RLL (RB7), LUL (LB1/2). Fiducials placed in all. No complications.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Bowers\n\nINDICATION FOR OPERATION: The patient is a 77-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 12; TV: 400; PEEP: 8; FiO2: 80%; Flow Rate: 12;\nPmean: 14.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Medial Basal Segment RB7) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Medial Basal Segment of the RLL (RB7).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with discontinuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Apical-Posterior Segment LB1/2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Apical-Posterior Segment of the LUL (LB1/2).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n77-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Operative Report. 70yo F, Dr. Weiss. Robotic bronch Ion 3 targets: RUL RB1, RLL RB7, LUL LB1/2. All fiducials placed. EBUS neg.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Weiss\n\nINDICATION FOR OPERATION: The patient is a 70-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Medial Basal Segment RB7) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Medial Basal Segment of the RLL (RB7).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with discontinuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Apical-Posterior Segment LB1/2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Apical-Posterior Segment of the LUL (LB1/2).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n70-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "PATIENT: 66 / F\nPROCEDURE: Ion Robotic Bronchoscopy + EBUS\nTARGETS:\n1. RUL RB2 (1.5 cm)\n2. RLL RB10 (0.8 cm)\n3. LUL LB3 (1.5 cm)\nFINDINGS: EBUS negative. Successful sampling of all nodules.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Chen\n\nINDICATION FOR OPERATION: The patient is a 66-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Posterior Basal Segment RB10) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Anterior Segment LB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Anterior Segment of the LUL (LB3).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n66-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Write an op note for a 69 year old female patient. Procedure was Robotic Navigation Bronchoscopy using the Ion system. We targeted three lesions: RUL Anterior Segment, RLL Superior Segment, and LUL Apical-Posterior Segment. We did TBNA, cryo, brush, and BAL for all. Also did EBUS staging, but no nodes were sampled.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Chen\n\nINDICATION FOR OPERATION: The patient is a 69-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Apical-Posterior Segment LB1/2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Apical-Posterior Segment of the LUL (LB1/2).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n69-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Procedure Code: Robotic Bronchoscopy with EBUS. Patient: 65 F. Targets: RUL RB2, RLL RB9, LUL LB4. Specimen collected: TBNA, Cryo, Brush, BAL. Fiducials placed.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Smith\n\nINDICATION FOR OPERATION: The patient is a 65-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Lateral Basal Segment RB9) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Lateral Basal Segment of the RLL (RB9).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n65-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "PATIENT: 63 / M\nPROCEDURE: Ion Robotic Bronchoscopy + EBUS\nTARGETS:\n1. RUL RB1 (1.8 cm)\n2. RLL RB9 (1.8 cm)\n3. LUL LB3 (1.2 cm)\nFINDINGS: EBUS negative. Successful sampling of all nodules.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Weiss\n\nINDICATION FOR OPERATION: The patient is a 63-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Lateral Basal Segment RB9) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Lateral Basal Segment of the RLL (RB9).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Anterior Segment LB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Anterior Segment of the LUL (LB3).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n63-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Procedure Code: Robotic Bronchoscopy with EBUS. Patient: 70 M. Targets: RUL RB1, RLL RB6, LUL LB1/2. Specimen collected: TBNA, Cryo, Brush, BAL. Fiducials placed.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Weiss\n\nINDICATION FOR OPERATION: The patient is a 70-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Apical-Posterior Segment LB1/2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Apical-Posterior Segment of the LUL (LB1/2).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n70-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Operative Report. 72yo F, Dr. Chen. Robotic bronch Ion 3 targets: RUL RB1, RLL RB6, LUL LB1/2. All fiducials placed. EBUS neg.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Chen\n\nINDICATION FOR OPERATION: The patient is a 72-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Apical-Posterior Segment LB1/2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Apical-Posterior Segment of the LUL (LB1/2).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n72-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Operative Report. 70yo F, Dr. Chen. Robotic bronch Ion 3 targets: RUL RB1, RLL RB9, LUL LB4. All fiducials placed. EBUS neg.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Chen\n\nINDICATION FOR OPERATION: The patient is a 70-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Lateral Basal Segment RB9) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Lateral Basal Segment of the RLL (RB9).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n70-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "PATIENT: 65 / M\nPROCEDURE: Ion Robotic Bronchoscopy + EBUS\nTARGETS:\n1. RUL RB2 (0.8 cm)\n2. RLL RB9 (1.8 cm)\n3. LUL LB3 (0.8 cm)\nFINDINGS: EBUS negative. Successful sampling of all nodules.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Rodriguez\n\nINDICATION FOR OPERATION: The patient is a 65-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Lateral Basal Segment RB9) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Lateral Basal Segment of the RLL (RB9).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with discontinuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Anterior Segment LB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Anterior Segment of the LUL (LB3).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n65-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "87 F lung nodules. Robotic bronch + EBUS. Targets: RUL (RB3), RLL (RB6), LUL (LB4). Fiducials placed in all. No complications.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Patel\n\nINDICATION FOR OPERATION: The patient is a 87-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n87-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Write an op note for a 76 year old female patient. Procedure was Robotic Navigation Bronchoscopy using the Ion system. We targeted three lesions: RUL Posterior Segment, RLL Lateral Basal Segment, and LUL Superior Lingular Segment. We did TBNA, cryo, brush, and BAL for all. Also did EBUS staging, but no nodes were sampled.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Chen\n\nINDICATION FOR OPERATION: The patient is a 76-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Lateral Basal Segment RB9) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Lateral Basal Segment of the RLL (RB9).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with discontinuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n76-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "82 F lung nodules. Robotic bronch + EBUS. Targets: RUL (RB2), RLL (RB9), LUL (LB3). Fiducials placed in all. No complications.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Chen\n\nINDICATION FOR OPERATION: The patient is a 82-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 12; TV: 400; PEEP: 8; FiO2: 80%; Flow Rate: 12;\nPmean: 14.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Lateral Basal Segment RB9) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Lateral Basal Segment of the RLL (RB9).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Anterior Segment LB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Anterior Segment of the LUL (LB3).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n82-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Write an op note for a 80 year old male patient. Procedure was Robotic Navigation Bronchoscopy using the Ion system. We targeted three lesions: RUL Apical Segment, RLL Lateral Basal Segment, and LUL Superior Lingular Segment. We did TBNA, cryo, brush, and BAL for all. Also did EBUS staging, but no nodes were sampled.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Smith\n\nINDICATION FOR OPERATION: The patient is a 80-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Lateral Basal Segment RB9) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Lateral Basal Segment of the RLL (RB9).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n80-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "81 F lung nodules. Robotic bronch + EBUS. Targets: RUL (RB3), RLL (RB7), LUL (LB1/2). Fiducials placed in all. No complications.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Bowers\n\nINDICATION FOR OPERATION: The patient is a 81-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Medial Basal Segment RB7) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Medial Basal Segment of the RLL (RB7).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Apical-Posterior Segment LB1/2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Apical-Posterior Segment of the LUL (LB1/2).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n81-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "PATIENT: 76 / F\nPROCEDURE: Ion Robotic Bronchoscopy + EBUS\nTARGETS:\n1. RUL RB3 (1.0 cm)\n2. RLL RB6 (2.1 cm)\n3. LUL LB4 (2.1 cm)\nFINDINGS: EBUS negative. Successful sampling of all nodules.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Patel\n\nINDICATION FOR OPERATION: The patient is a 76-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n76-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "PATIENT: 55 / F\nPROCEDURE: Ion Robotic Bronchoscopy + EBUS\nTARGETS:\n1. RUL RB2 (0.8 cm)\n2. RLL RB6 (1.5 cm)\n3. LUL LB4 (2.1 cm)\nFINDINGS: EBUS negative. Successful sampling of all nodules.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Smith\n\nINDICATION FOR OPERATION: The patient is a 55-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n55-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Procedure Code: Robotic Bronchoscopy with EBUS. Patient: 85 M. Targets: RUL RB3, RLL RB7, LUL LB3. Specimen collected: TBNA, Cryo, Brush, BAL. Fiducials placed.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Smith\n\nINDICATION FOR OPERATION: The patient is a 85-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 12; TV: 400; PEEP: 8; FiO2: 80%; Flow Rate: 12;\nPmean: 14.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Medial Basal Segment RB7) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Medial Basal Segment of the RLL (RB7).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Anterior Segment LB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Anterior Segment of the LUL (LB3).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n85-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Procedure Code: Robotic Bronchoscopy with EBUS. Patient: 62 M. Targets: RUL RB2, RLL RB9, LUL LB4. Specimen collected: TBNA, Cryo, Brush, BAL. Fiducials placed.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Chen\n\nINDICATION FOR OPERATION: The patient is a 62-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Lateral Basal Segment RB9) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Lateral Basal Segment of the RLL (RB9).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with discontinuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n62-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Write an op note for a 55 year old male patient. Procedure was Robotic Navigation Bronchoscopy using the Ion system. We targeted three lesions: RUL Posterior Segment, RLL Medial Basal Segment, and LUL Superior Lingular Segment. We did TBNA, cryo, brush, and BAL for all. Also did EBUS staging, but no nodes were sampled.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Rodriguez\n\nINDICATION FOR OPERATION: The patient is a 55-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Medial Basal Segment RB7) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Medial Basal Segment of the RLL (RB7).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n55-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "64 F lung nodules. Robotic bronch + EBUS. Targets: RUL (RB3), RLL (RB6), LUL (LB4). Fiducials placed in all. No complications.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Rodriguez\n\nINDICATION FOR OPERATION: The patient is a 64-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 12; TV: 400; PEEP: 8; FiO2: 80%; Flow Rate: 12;\nPmean: 14.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n64-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Write an op note for a 78 year old female patient. Procedure was Robotic Navigation Bronchoscopy using the Ion system. We targeted three lesions: RUL Anterior Segment, RLL Medial Basal Segment, and LUL Superior Lingular Segment. We did TBNA, cryo, brush, and BAL for all. Also did EBUS staging, but no nodes were sampled.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Weiss\n\nINDICATION FOR OPERATION: The patient is a 78-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Medial Basal Segment RB7) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Medial Basal Segment of the RLL (RB7).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n78-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Write an op note for a 56 year old male patient. Procedure was Robotic Navigation Bronchoscopy using the Ion system. We targeted three lesions: RUL Apical Segment, RLL Posterior Basal Segment, and LUL Superior Lingular Segment. We did TBNA, cryo, brush, and BAL for all. Also did EBUS staging, but no nodes were sampled.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Chen\n\nINDICATION FOR OPERATION: The patient is a 56-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Posterior Basal Segment RB10) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n56-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "62 M lung nodules. Robotic bronch + EBUS. Targets: RUL (RB2), RLL (RB9), LUL (LB3). Fiducials placed in all. No complications.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Smith\n\nINDICATION FOR OPERATION: The patient is a 62-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Lateral Basal Segment RB9) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Lateral Basal Segment of the RLL (RB9).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Anterior Segment LB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Anterior Segment of the LUL (LB3).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n62-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Procedure Code: Robotic Bronchoscopy with EBUS. Patient: 72 F. Targets: RUL RB2, RLL RB9, LUL LB4. Specimen collected: TBNA, Cryo, Brush, BAL. Fiducials placed.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Bowers\n\nINDICATION FOR OPERATION: The patient is a 72-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 12; TV: 400; PEEP: 8; FiO2: 80%; Flow Rate: 12;\nPmean: 14.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Lateral Basal Segment RB9) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Lateral Basal Segment of the RLL (RB9).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n72-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Procedure Code: Robotic Bronchoscopy with EBUS. Patient: 68 F. Targets: RUL RB2, RLL RB6, LUL LB4. Specimen collected: TBNA, Cryo, Brush, BAL. Fiducials placed.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Patel\n\nINDICATION FOR OPERATION: The patient is a 68-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n68-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Operative Report. 60yo M, Dr. Smith. Robotic bronch Ion 3 targets: RUL RB1, RLL RB10, LUL LB3. All fiducials placed. EBUS neg.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Smith\n\nINDICATION FOR OPERATION: The patient is a 60-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 12; TV: 400; PEEP: 8; FiO2: 80%; Flow Rate: 12;\nPmean: 14.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Posterior Basal Segment RB10) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Anterior Segment LB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Anterior Segment of the LUL (LB3).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n60-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Operative Report. 59yo M, Dr. Smith. Robotic bronch Ion 3 targets: RUL RB1, RLL RB10, LUL LB1/2. All fiducials placed. EBUS neg.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Smith\n\nINDICATION FOR OPERATION: The patient is a 59-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Posterior Basal Segment RB10) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Apical-Posterior Segment LB1/2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Apical-Posterior Segment of the LUL (LB1/2).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n59-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Procedure Code: Robotic Bronchoscopy with EBUS. Patient: 68 M. Targets: RUL RB3, RLL RB6, LUL LB3. Specimen collected: TBNA, Cryo, Brush, BAL. Fiducials placed.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Patel\n\nINDICATION FOR OPERATION: The patient is a 68-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Anterior Segment LB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Anterior Segment of the LUL (LB3).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n68-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Procedure Code: Robotic Bronchoscopy with EBUS. Patient: 61 F. Targets: RUL RB2, RLL RB6, LUL LB1/2. Specimen collected: TBNA, Cryo, Brush, BAL. Fiducials placed.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Weiss\n\nINDICATION FOR OPERATION: The patient is a 61-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Apical-Posterior Segment LB1/2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Apical-Posterior Segment of the LUL (LB1/2).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n61-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Write an op note for a 78 year old female patient. Procedure was Robotic Navigation Bronchoscopy using the Ion system. We targeted three lesions: RUL Posterior Segment, RLL Medial Basal Segment, and LUL Superior Lingular Segment. We did TBNA, cryo, brush, and BAL for all. Also did EBUS staging, but no nodes were sampled.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Weiss\n\nINDICATION FOR OPERATION: The patient is a 78-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 12; TV: 400; PEEP: 8; FiO2: 80%; Flow Rate: 12;\nPmean: 14.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Medial Basal Segment RB7) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Medial Basal Segment of the RLL (RB7).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n78-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Procedure Code: Robotic Bronchoscopy with EBUS. Patient: 81 F. Targets: RUL RB2, RLL RB9, LUL LB3. Specimen collected: TBNA, Cryo, Brush, BAL. Fiducials placed.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Bowers\n\nINDICATION FOR OPERATION: The patient is a 81-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Lateral Basal Segment RB9) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Lateral Basal Segment of the RLL (RB9).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Anterior Segment LB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Anterior Segment of the LUL (LB3).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n81-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Procedure Code: Robotic Bronchoscopy with EBUS. Patient: 60 F. Targets: RUL RB3, RLL RB6, LUL LB4. Specimen collected: TBNA, Cryo, Brush, BAL. Fiducials placed.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Smith\n\nINDICATION FOR OPERATION: The patient is a 60-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n60-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "PATIENT: 81 / F\nPROCEDURE: Ion Robotic Bronchoscopy + EBUS\nTARGETS:\n1. RUL RB1 (1.2 cm)\n2. RLL RB6 (1.0 cm)\n3. LUL LB1/2 (0.8 cm)\nFINDINGS: EBUS negative. Successful sampling of all nodules.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Smith\n\nINDICATION FOR OPERATION: The patient is a 81-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Apical-Posterior Segment LB1/2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Apical-Posterior Segment of the LUL (LB1/2).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n81-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Operative Report. 68yo F, Dr. Weiss. Robotic bronch Ion 3 targets: RUL RB1, RLL RB10, LUL LB4. All fiducials placed. EBUS neg.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Weiss\n\nINDICATION FOR OPERATION: The patient is a 68-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Posterior Basal Segment RB10) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n68-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "75 M lung nodules. Robotic bronch + EBUS. Targets: RUL (RB1), RLL (RB7), LUL (LB1/2). Fiducials placed in all. No complications.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Rodriguez\n\nINDICATION FOR OPERATION: The patient is a 75-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Medial Basal Segment RB7) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Medial Basal Segment of the RLL (RB7).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Apical-Posterior Segment LB1/2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Apical-Posterior Segment of the LUL (LB1/2).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n75-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "PATIENT: 82 / M\nPROCEDURE: Ion Robotic Bronchoscopy + EBUS\nTARGETS:\n1. RUL RB3 (1.8 cm)\n2. RLL RB7 (2.1 cm)\n3. LUL LB3 (2.1 cm)\nFINDINGS: EBUS negative. Successful sampling of all nodules.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Rodriguez\n\nINDICATION FOR OPERATION: The patient is a 82-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Medial Basal Segment RB7) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Medial Basal Segment of the RLL (RB7).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Anterior Segment LB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Anterior Segment of the LUL (LB3).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n82-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Operative Report. 63yo F, Dr. Weiss. Robotic bronch Ion 3 targets: RUL RB2, RLL RB7, LUL LB1/2. All fiducials placed. EBUS neg.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Weiss\n\nINDICATION FOR OPERATION: The patient is a 63-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Medial Basal Segment RB7) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Medial Basal Segment of the RLL (RB7).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Apical-Posterior Segment LB1/2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Apical-Posterior Segment of the LUL (LB1/2).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n63-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Write an op note for a 78 year old female patient. Procedure was Robotic Navigation Bronchoscopy using the Ion system. We targeted three lesions: RUL Posterior Segment, RLL Superior Segment, and LUL Apical-Posterior Segment. We did TBNA, cryo, brush, and BAL for all. Also did EBUS staging, but no nodes were sampled.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Patel\n\nINDICATION FOR OPERATION: The patient is a 78-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Apical-Posterior Segment LB1/2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Apical-Posterior Segment of the LUL (LB1/2).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n78-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Write an op note for a 73 year old female patient. Procedure was Robotic Navigation Bronchoscopy using the Ion system. We targeted three lesions: RUL Posterior Segment, RLL Superior Segment, and LUL Apical-Posterior Segment. We did TBNA, cryo, brush, and BAL for all. Also did EBUS staging, but no nodes were sampled.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Bowers\n\nINDICATION FOR OPERATION: The patient is a 73-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Apical-Posterior Segment LB1/2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Apical-Posterior Segment of the LUL (LB1/2).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n73-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Operative Report. 75yo M, Dr. Bowers. Robotic bronch Ion 3 targets: RUL RB3, RLL RB9, LUL LB4. All fiducials placed. EBUS neg.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Bowers\n\nINDICATION FOR OPERATION: The patient is a 75-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Lateral Basal Segment RB9) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Lateral Basal Segment of the RLL (RB9).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with discontinuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n75-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Write an op note for a 73 year old female patient. Procedure was Robotic Navigation Bronchoscopy using the Ion system. We targeted three lesions: RUL Apical Segment, RLL Lateral Basal Segment, and LUL Apical-Posterior Segment. We did TBNA, cryo, brush, and BAL for all. Also did EBUS staging, but no nodes were sampled.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Weiss\n\nINDICATION FOR OPERATION: The patient is a 73-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 12; TV: 400; PEEP: 8; FiO2: 80%; Flow Rate: 12;\nPmean: 14.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Lateral Basal Segment RB9) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Lateral Basal Segment of the RLL (RB9).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Apical-Posterior Segment LB1/2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Apical-Posterior Segment of the LUL (LB1/2).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n73-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Write an op note for a 77 year old female patient. Procedure was Robotic Navigation Bronchoscopy using the Ion system. We targeted three lesions: RUL Apical Segment, RLL Lateral Basal Segment, and LUL Anterior Segment. We did TBNA, cryo, brush, and BAL for all. Also did EBUS staging, but no nodes were sampled.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Weiss\n\nINDICATION FOR OPERATION: The patient is a 77-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Lateral Basal Segment RB9) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Lateral Basal Segment of the RLL (RB9).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Anterior Segment LB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Anterior Segment of the LUL (LB3).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n77-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "PATIENT: 71 / F\nPROCEDURE: Ion Robotic Bronchoscopy + EBUS\nTARGETS:\n1. RUL RB1 (1.0 cm)\n2. RLL RB6 (1.8 cm)\n3. LUL LB1/2 (1.5 cm)\nFINDINGS: EBUS negative. Successful sampling of all nodules.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Chen\n\nINDICATION FOR OPERATION: The patient is a 71-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 12; TV: 400; PEEP: 8; FiO2: 80%; Flow Rate: 12;\nPmean: 14.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Apical-Posterior Segment LB1/2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Apical-Posterior Segment of the LUL (LB1/2).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n71-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "PATIENT: 56 / F\nPROCEDURE: Ion Robotic Bronchoscopy + EBUS\nTARGETS:\n1. RUL RB1 (2.1 cm)\n2. RLL RB10 (1.2 cm)\n3. LUL LB1/2 (0.8 cm)\nFINDINGS: EBUS negative. Successful sampling of all nodules.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Chen\n\nINDICATION FOR OPERATION: The patient is a 56-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Posterior Basal Segment RB10) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with discontinuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Apical-Posterior Segment LB1/2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Apical-Posterior Segment of the LUL (LB1/2).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n56-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Operative Report. 59yo F, Dr. Weiss. Robotic bronch Ion 3 targets: RUL RB2, RLL RB6, LUL LB4. All fiducials placed. EBUS neg.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Weiss\n\nINDICATION FOR OPERATION: The patient is a 59-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with discontinuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n59-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Operative Report. 69yo M, Dr. Chen. Robotic bronch Ion 3 targets: RUL RB1, RLL RB10, LUL LB1/2. All fiducials placed. EBUS neg.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Chen\n\nINDICATION FOR OPERATION: The patient is a 69-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Posterior Basal Segment RB10) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Apical-Posterior Segment LB1/2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Apical-Posterior Segment of the LUL (LB1/2).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n69-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Procedure Code: Robotic Bronchoscopy with EBUS. Patient: 58 M. Targets: RUL RB3, RLL RB10, LUL LB4. Specimen collected: TBNA, Cryo, Brush, BAL. Fiducials placed.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Rodriguez\n\nINDICATION FOR OPERATION: The patient is a 58-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Posterior Basal Segment RB10) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with discontinuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n58-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Write an op note for a 76 year old male patient. Procedure was Robotic Navigation Bronchoscopy using the Ion system. We targeted three lesions: RUL Posterior Segment, RLL Posterior Basal Segment, and LUL Superior Lingular Segment. We did TBNA, cryo, brush, and BAL for all. Also did EBUS staging, but no nodes were sampled.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Patel\n\nINDICATION FOR OPERATION: The patient is a 76-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Posterior Basal Segment RB10) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n76-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Procedure Code: Robotic Bronchoscopy with EBUS. Patient: 58 F. Targets: RUL RB1, RLL RB7, LUL LB4. Specimen collected: TBNA, Cryo, Brush, BAL. Fiducials placed.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Bowers\n\nINDICATION FOR OPERATION: The patient is a 58-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Medial Basal Segment RB7) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Medial Basal Segment of the RLL (RB7).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n58-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Procedure Code: Robotic Bronchoscopy with EBUS. Patient: 58 F. Targets: RUL RB1, RLL RB7, LUL LB4. Specimen collected: TBNA, Cryo, Brush, BAL. Fiducials placed.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Smith\n\nINDICATION FOR OPERATION: The patient is a 58-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Medial Basal Segment RB7) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Medial Basal Segment of the RLL (RB7).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n58-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Operative Report. 71yo F, Dr. Chen. Robotic bronch Ion 3 targets: RUL RB3, RLL RB9, LUL LB1/2. All fiducials placed. EBUS neg.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Chen\n\nINDICATION FOR OPERATION: The patient is a 71-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Lateral Basal Segment RB9) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Lateral Basal Segment of the RLL (RB9).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Apical-Posterior Segment LB1/2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Apical-Posterior Segment of the LUL (LB1/2).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n71-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Procedure Code: Robotic Bronchoscopy with EBUS. Patient: 58 M. Targets: RUL RB1, RLL RB9, LUL LB4. Specimen collected: TBNA, Cryo, Brush, BAL. Fiducials placed.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Rodriguez\n\nINDICATION FOR OPERATION: The patient is a 58-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Lateral Basal Segment RB9) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Lateral Basal Segment of the RLL (RB9).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n58-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Procedure Code: Robotic Bronchoscopy with EBUS. Patient: 62 M. Targets: RUL RB1, RLL RB6, LUL LB4. Specimen collected: TBNA, Cryo, Brush, BAL. Fiducials placed.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Patel\n\nINDICATION FOR OPERATION: The patient is a 62-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with discontinuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n62-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Write an op note for a 65 year old male patient. Procedure was Robotic Navigation Bronchoscopy using the Ion system. We targeted three lesions: RUL Apical Segment, RLL Medial Basal Segment, and LUL Anterior Segment. We did TBNA, cryo, brush, and BAL for all. Also did EBUS staging, but no nodes were sampled.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Chen\n\nINDICATION FOR OPERATION: The patient is a 65-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Medial Basal Segment RB7) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Medial Basal Segment of the RLL (RB7).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Anterior Segment LB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Anterior Segment of the LUL (LB3).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n65-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Procedure Code: Robotic Bronchoscopy with EBUS. Patient: 64 M. Targets: RUL RB2, RLL RB10, LUL LB4. Specimen collected: TBNA, Cryo, Brush, BAL. Fiducials placed.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Rodriguez\n\nINDICATION FOR OPERATION: The patient is a 64-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Posterior Basal Segment RB10) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with discontinuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n64-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "68 M lung nodules. Robotic bronch + EBUS. Targets: RUL (RB3), RLL (RB7), LUL (LB1/2). Fiducials placed in all. No complications.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Patel\n\nINDICATION FOR OPERATION: The patient is a 68-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Medial Basal Segment RB7) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Medial Basal Segment of the RLL (RB7).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Apical-Posterior Segment LB1/2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Apical-Posterior Segment of the LUL (LB1/2).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n68-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Procedure Code: Robotic Bronchoscopy with EBUS. Patient: 80 F. Targets: RUL RB1, RLL RB7, LUL LB3. Specimen collected: TBNA, Cryo, Brush, BAL. Fiducials placed.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Rodriguez\n\nINDICATION FOR OPERATION: The patient is a 80-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Medial Basal Segment RB7) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Medial Basal Segment of the RLL (RB7).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Anterior Segment LB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Anterior Segment of the LUL (LB3).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n80-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Operative Report. 62yo F, Dr. Chen. Robotic bronch Ion 3 targets: RUL RB2, RLL RB10, LUL LB4. All fiducials placed. EBUS neg.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Chen\n\nINDICATION FOR OPERATION: The patient is a 62-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Posterior Basal Segment RB10) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with discontinuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n62-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "58 M lung nodules. Robotic bronch + EBUS. Targets: RUL (RB1), RLL (RB7), LUL (LB4). Fiducials placed in all. No complications.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Rodriguez\n\nINDICATION FOR OPERATION: The patient is a 58-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 12; TV: 400; PEEP: 8; FiO2: 80%; Flow Rate: 12;\nPmean: 14.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Medial Basal Segment RB7) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Medial Basal Segment of the RLL (RB7).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n58-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "72 F lung nodules. Robotic bronch + EBUS. Targets: RUL (RB3), RLL (RB6), LUL (LB4). Fiducials placed in all. No complications.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Bowers\n\nINDICATION FOR OPERATION: The patient is a 72-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n72-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "68 F lung nodules. Robotic bronch + EBUS. Targets: RUL (RB3), RLL (RB10), LUL (LB4). Fiducials placed in all. No complications.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Patel\n\nINDICATION FOR OPERATION: The patient is a 68-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Posterior Basal Segment RB10) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n68-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "74 M lung nodules. Robotic bronch + EBUS. Targets: RUL (RB3), RLL (RB10), LUL (LB4). Fiducials placed in all. No complications.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Rodriguez\n\nINDICATION FOR OPERATION: The patient is a 74-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Posterior Basal Segment RB10) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n74-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Procedure Code: Robotic Bronchoscopy with EBUS. Patient: 82 F. Targets: RUL RB3, RLL RB7, LUL LB4. Specimen collected: TBNA, Cryo, Brush, BAL. Fiducials placed.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Smith\n\nINDICATION FOR OPERATION: The patient is a 82-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Medial Basal Segment RB7) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Medial Basal Segment of the RLL (RB7).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n82-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "65 M lung nodules. Robotic bronch + EBUS. Targets: RUL (RB1), RLL (RB9), LUL (LB4). Fiducials placed in all. No complications.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Bowers\n\nINDICATION FOR OPERATION: The patient is a 65-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Lateral Basal Segment RB9) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Lateral Basal Segment of the RLL (RB9).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n65-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "58 M lung nodules. Robotic bronch + EBUS. Targets: RUL (RB1), RLL (RB9), LUL (LB1/2). Fiducials placed in all. No complications.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Rodriguez\n\nINDICATION FOR OPERATION: The patient is a 58-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Lateral Basal Segment RB9) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Lateral Basal Segment of the RLL (RB9).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Apical-Posterior Segment LB1/2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Apical-Posterior Segment of the LUL (LB1/2).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n58-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Operative Report. 85yo M, Dr. Patel. Robotic bronch Ion 3 targets: RUL RB2, RLL RB9, LUL LB1/2. All fiducials placed. EBUS neg.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Patel\n\nINDICATION FOR OPERATION: The patient is a 85-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Lateral Basal Segment RB9) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Lateral Basal Segment of the RLL (RB9).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Apical-Posterior Segment LB1/2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Apical-Posterior Segment of the LUL (LB1/2).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n85-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Operative Report. 75yo M, Dr. Rodriguez. Robotic bronch Ion 3 targets: RUL RB3, RLL RB6, LUL LB3. All fiducials placed. EBUS neg.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Rodriguez\n\nINDICATION FOR OPERATION: The patient is a 75-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 12; TV: 400; PEEP: 8; FiO2: 80%; Flow Rate: 12;\nPmean: 14.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Anterior Segment LB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Anterior Segment of the LUL (LB3).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n75-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "PATIENT: 57 / M\nPROCEDURE: Ion Robotic Bronchoscopy + EBUS\nTARGETS:\n1. RUL RB3 (0.8 cm)\n2. RLL RB6 (0.8 cm)\n3. LUL LB4 (1.2 cm)\nFINDINGS: EBUS negative. Successful sampling of all nodules.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Smith\n\nINDICATION FOR OPERATION: The patient is a 57-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 12; TV: 400; PEEP: 8; FiO2: 80%; Flow Rate: 12;\nPmean: 14.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n57-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Operative Report. 73yo M, Dr. Smith. Robotic bronch Ion 3 targets: RUL RB3, RLL RB6, LUL LB3. All fiducials placed. EBUS neg.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Smith\n\nINDICATION FOR OPERATION: The patient is a 73-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Anterior Segment LB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Anterior Segment of the LUL (LB3).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n73-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Operative Report. 79yo M, Dr. Chen. Robotic bronch Ion 3 targets: RUL RB3, RLL RB10, LUL LB3. All fiducials placed. EBUS neg.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Chen\n\nINDICATION FOR OPERATION: The patient is a 79-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Posterior Basal Segment RB10) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with discontinuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Anterior Segment LB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Anterior Segment of the LUL (LB3).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n79-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "PATIENT: 85 / M\nPROCEDURE: Ion Robotic Bronchoscopy + EBUS\nTARGETS:\n1. RUL RB1 (1.5 cm)\n2. RLL RB7 (2.1 cm)\n3. LUL LB4 (1.8 cm)\nFINDINGS: EBUS negative. Successful sampling of all nodules.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Patel\n\nINDICATION FOR OPERATION: The patient is a 85-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Medial Basal Segment RB7) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Medial Basal Segment of the RLL (RB7).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Superior Lingular Segment LB4) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Lingular Segment of the LUL (LB4).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n85-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Operative Report. 77yo F, Dr. Weiss. Robotic bronch Ion 3 targets: RUL RB2, RLL RB6, LUL LB3. All fiducials placed. EBUS neg.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Weiss\n\nINDICATION FOR OPERATION: The patient is a 77-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 12; TV: 400; PEEP: 8; FiO2: 80%; Flow Rate: 12;\nPmean: 14.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Anterior Segment LB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Anterior Segment of the LUL (LB3).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included slightly irregular margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n77-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "PATIENT: 76 / F\nPROCEDURE: Ion Robotic Bronchoscopy + EBUS\nTARGETS:\n1. RUL RB1 (2.1 cm)\n2. RLL RB6 (0.8 cm)\n3. LUL LB3 (1.5 cm)\nFINDINGS: EBUS negative. Successful sampling of all nodules.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Weiss\n\nINDICATION FOR OPERATION: The patient is a 76-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 350; PEEP: 10; FiO2: 100%; Flow Rate: 10;\nPmean: 15.\n\nRUL Target (Apical Segment RB1) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion is about 2.1 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 40 cc NS, return 15 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Superior Segment RB6) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Superior Segment of the RLL (RB6).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a eccentric nodule location with continuous margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Anterior Segment LB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Anterior Segment of the LUL (LB3).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 5 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n76-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "58 F lung nodules. Robotic bronch + EBUS. Targets: RUL (RB3), RLL (RB9), LUL (LB3). Fiducials placed in all. No complications.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Bowers\n\nINDICATION FOR OPERATION: The patient is a 58-year-old female who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Anterior Segment RB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Anterior Segment of the RUL (RB3).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 4 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 8 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Lateral Basal Segment RB9) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Lateral Basal Segment of the RLL (RB9).\nThe target lesion is about 0.8 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with continuous margins.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 5 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Anterior Segment LB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Anterior Segment of the LUL (LB3).\nThe target lesion is about 1.5 cm in diameter, and the catheter was advanced to touching the target away from the planned target.\nrEBUS: Radial EBUS confirmed an concentric nodule location. Features noted included continuous margins and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n58-year-old female who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
{"prompt": "Procedure Code: Robotic Bronchoscopy with EBUS. Patient: 55 M. Targets: RUL RB2, RLL RB10, LUL LB3. Specimen collected: TBNA, Cryo, Brush, BAL. Fiducials placed.", "completion": "NOTE_ID: note_066\nDATE OF PROCEDURE: [Date]\n\nATTENDING PHYSICIAN: Dr. Chen\n\nINDICATION FOR OPERATION: The patient is a 55-year-old male who presents with lung nodules.\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\nCONSENT Obtained before the procedure.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary pulmonary nodule.\n\nPROCEDURE\nRobotic navigation bronchoscopy (Ion) to RUL, RLL, and LUL targets.\nRadial EBUS for peripheral lesions.\nCone-beam CT (Cios Spin) with 3D rendering and instrument guidance.\nTransbronchial needle aspiration (TBNA) of single and additional lobes.\nTransbronchial biopsy (TBBX) of single and additional lobes.\nTransbronchial cryobiopsy.\nTransbronchial brushing.\nBronchoalveolar lavage (BAL).\nFiducial marker placement.\nBronchoscopy with Endobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes without biopsy.\n\nANESTHESIA General Anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION Linear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope, Cios Spin system.\n\nESTIMATED BLOOD LOSS None.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nA CT Chest scan was placed on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic bronchoscopy platform.\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nVentilation Parameters: Mode: PCV; RR: 16; TV: 300; PEEP: 12; FiO2: 100%; Flow Rate: 10;\nPmean: 18.\n\nRUL Target (Posterior Segment RB2) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion is about 1.2 cm in diameter, and the catheter was advanced to 0.5 cm away from the planned target under navigational guidance.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included discontinuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed for evaluation of nodule location.\n3D reconstructions were performed on an independent workstation and passed to the Ion platform.\nThe robotic system was adjusted to the new targeted location based on this imaging.\n\nSampling:\nTBNA: performed with 21G needle; 5 samples collected and sent for cytology.\nTBBX: performed with alligator forceps; 1 sample collected and sent for pathology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 3 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 20 cc NS, return 10 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nRLL Target (Posterior Basal Segment RB10) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion is about 1.8 cm in diameter, and the catheter was advanced to 1.5 cm away from the planned target.\nrEBUS: Radial EBUS confirmed a concentric nodule location with slightly irregular margin.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 4 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 50 cc NS, return 20 cc; sent for cell count, microbiology, and cytology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nLUL Target (Anterior Segment LB3) Robotic navigation bronchoscopy was performed with the Ion platform using partial registration to engage the Anterior Segment of the LUL (LB3).\nThe target lesion is about 1.0 cm in diameter, and the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS: Radial EBUS confirmed an eccentric nodule location. Features noted included continuous margin and absence of linear-discrete air bronchogram.\nImaging: Cone Beam CT (Cios Spin) was performed with 3D reconstruction to evaluate and adjust nodule location.\nSampling:\nTBNA: performed with 21G needle; 3 samples collected and sent for cytology.\nCryobiopsy: performed with 1.1mm cryoprobe (6-second freeze); 6 samples collected and sent for pathology.\nBrushing: performed with protected cytology brush; 1 sample collected and sent for microbiology.\nBAL: Instilled 30 cc NS, return 12 cc; sent for microbiology.\nFiducial Marker: One 0.9mm x 4mm coil marker was placed under fluoroscopy guidance.\nROSE: No evidence of malignant neoplasm.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.\n\nEBUS STAGING\nIndications: Diagnostic. Technique: All lymph node stations were assessed.\nOnly those 5 mm or greater in short axis were considered for sampling.\nLymph Nodes Inspected:\n4R (lower paratracheal)\n4L (lower paratracheal)\n7 (subcarinal)\n10R, 10L (hilar)\n11Rs, 11Ri, 11L (interlobar).\nFindings: Lymph node sizing was performed by EBUS; no sampling was done as none met biopsy criteria.\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness (Type 1\u20133).\n\nCONCLUSION The patient tolerated the procedure well.\nThere were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\nRUL: TBNA, TBCBX, Brush, BAL, TBBX.\nRLL: TBNA, TBCBX, Brush, BAL.\nLUL: TBNA, TBCBX, Brush, BAL.\n\nIMPRESSION / PLAN\n55-year-old male who presented for bronchoscopy for lung nodules.\nSuccessful sampling of RUL, RLL, and LUL nodules using robotic navigation and cone-beam CT guidance.\nFollow up in clinic for results.\n"}
